市场调查报告书
商品编码
1451229
2024-2032 年按产品类型(治疗设备、诊断设备)、最终用户(医院和诊所、睡眠实验室、家庭护理机构等)和地区分類的睡眠呼吸中止设备市场报告Sleep Apnea Devices Market Report by Product Type (Therapeutic Devices, Diagnostic Devices), End-User (Hospitals and Clinics, Sleep Laboratories, Homecare Settings, and Others), and Region 2024-2032 |
2023 年,全球睡眠呼吸中止设备市场规模达到 80 亿美元。展望未来, IMARC Group预计到 2032 年,市场规模将达到 138 亿美元,2024-2032 年复合年增长率 (CAGR) 为 6%。
睡眠呼吸中止症或睡眠呼吸障碍 (SDB) 是一种急性疾病,患者在睡眠期间大脑的供氧受到阻碍。它是由气道阻塞引起的,导致呼吸模式不规则和打鼾声大,患者经常喘气。睡眠呼吸中止症诊断和治疗设备,例如持续性正压呼吸器(CPAP)、双水平气道正压通气(BiPAP) 和可变气道正压通气(VPAP) 机,用于评估患者在睡眠期间的呼吸和其他身体功能。除此之外,许多口腔装置,包括下颚前移装置(MAD)和舌头固定装置,也用于治疗轻度至中度睡眠呼吸中止症病例。
阻塞性睡眠呼吸中止症(OSA)、中枢性睡眠呼吸中止症和复杂睡眠呼吸中止症候群的盛行率不断增加,是推动市场成长的关键因素之一。此类疾病在老年人群和患有糖尿病、高血压和心血管疾病 (CVD) 等其他疾病的个体中非常普遍,这促进了产品在已开发国家和新兴国家的采用。此外,产品创新,包括检查睡眠模式、心血管、血氧测定和呼吸参数以诊断 OSA 的中心外 (OOC) 测试设备,也是另一个主要的成长诱导因素。其他因素,包括医疗保健基础设施的改善、人们对睡眠呼吸中止长期影响的认识不断提高,以及各种品牌的小型化和推出价格实惠的设备,预计将进一步推动市场发展。
阻塞性睡眠呼吸中止症(OSA)、中枢性睡眠呼吸中止症和复杂睡眠呼吸中止症候群的盛行率不断增加,是推动市场成长的关键因素之一。此类疾病在老年人群和患有糖尿病、高血压和心血管疾病 (CVD) 等其他疾病的个体中非常普遍,这促进了产品在已开发国家和新兴国家的采用。此外,产品创新,包括检查睡眠模式、心血管、血氧测定和呼吸参数以诊断 OSA 的中心外 (OOC) 测试设备,也是另一个主要的成长诱导因素。其他因素,包括医疗保健基础设施的改善、人们对睡眠呼吸中止长期影响的认识不断提高,以及各种品牌的小型化和推出价格实惠的设备,预计将进一步推动市场发展。
The global sleep apnea devices market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032.
Sleep apnea, or sleep-disordered breathing (SDB), is an acute medical condition in which oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Sleep apnea diagnostic and therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Variable Positive Airway Pressure (VPAP) machines, are used to evaluate the patient's respiratory and other bodily functions during sleep. Apart from this, numerous oral devices, including the Mandibular Advancement Device (MAD) and tongue retaining device, are also utilized to treat mild to moderate cases of sleep apnea.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global sleep apnea devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and end-user.
Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Oral Devices
Nasal Devices
Chin Straps
Others
Diagnostic Devices
Actigraphs
Polysomnography Devices
Sleep Screening Devices
Others
Hospitals and Clinics
Sleep Laboratories
Homecare Settings
Others
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
The competitive landscape of the industry has also been examined with some of the key players being BMC Medical Co., Braebon Medical Corporation, Cadwell Laboratories, CareFusion Corp., Curative Medical, Devilbiss Healthcare, Fisher & Paykel Healthcare, GE Healthcare, Invacare, Oventus Medical, Panthera Dental, ResMed, Somnomed Ltd., Vyaire Medical Inc., Whole You Inc., etc.